45
Participants
Start Date
June 13, 2022
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
Carboplatin
Given IV
Cisplatin
Given IV
Cytoreductive Surgery
Undergo CRS
Hyperthermic Intraperitoneal Chemotherapy
Undergo HIPEC
Paclitaxel
Given IV
Quality-of-Life Assessment
Ancillary studies
Questionnaire Administration
Ancillary studies
Biospecimen Collection
Undergo stool sample collection
Diagnostic Imaging
Undergo diagnostic imaging
RECRUITING
Ohio State University Comprehensive Cancer Center, Columbus
Ohio State University Comprehensive Cancer Center
OTHER